FI882397A7 - Rokote ja valmistusmenetelmä - Google Patents

Rokote ja valmistusmenetelmä Download PDF

Info

Publication number
FI882397A7
FI882397A7 FI882397A FI882397A FI882397A7 FI 882397 A7 FI882397 A7 FI 882397A7 FI 882397 A FI882397 A FI 882397A FI 882397 A FI882397 A FI 882397A FI 882397 A7 FI882397 A7 FI 882397A7
Authority
FI
Finland
Prior art keywords
vaccine
manufacturing
Prior art date
Application number
FI882397A
Other languages
English (en)
Swedish (sv)
Other versions
FI882397L (fi
FI882397A0 (fi
Inventor
Robert L Hunter
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory filed Critical Univ Emory
Publication of FI882397A7 publication Critical patent/FI882397A7/fi
Publication of FI882397L publication Critical patent/FI882397L/fi
Publication of FI882397A0 publication Critical patent/FI882397A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI882397A 1986-09-22 1987-08-19 Vaccin och framstaellningsfoerfarande. FI882397A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90996486A 1986-09-22 1986-09-22
US7518787A 1987-07-16 1987-07-16
PCT/US1987/002056 WO1988001873A1 (en) 1986-09-22 1987-08-19 Vaccine and method of preparation

Publications (3)

Publication Number Publication Date
FI882397A7 true FI882397A7 (fi) 1988-05-20
FI882397L FI882397L (fi) 1988-05-20
FI882397A0 FI882397A0 (fi) 1988-05-20

Family

ID=26756538

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882397A FI882397A0 (fi) 1986-09-22 1987-08-19 Vaccin och framstaellningsfoerfarande.

Country Status (17)

Country Link
EP (1) EP0283505B1 (fi)
JP (1) JPH01501064A (fi)
KR (1) KR920002165B1 (fi)
CN (1) CN1030019A (fi)
AP (1) AP8700068A0 (fi)
AT (1) ATE108067T1 (fi)
BR (1) BR8707471A (fi)
CA (1) CA1322721C (fi)
DE (1) DE3750176T2 (fi)
DK (1) DK272688A (fi)
ES (1) ES2007720A6 (fi)
FI (1) FI882397A0 (fi)
GR (1) GR871460B (fi)
IL (1) IL83953A (fi)
NZ (2) NZ236829A (fi)
PT (1) PT85760B (fi)
WO (1) WO1988001873A1 (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226811A (en) * 1987-11-03 1991-06-25 Syntex Inc Adjuvant emulsion comprising a glycopeptide and non-toxic tetra-polyol or pop-poe block copolymer wherein oily particle size is less than 800am
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
CA2407897A1 (en) 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
KR20020032772A (ko) * 2000-10-27 2002-05-04 김정우 살모넬라균에 대한 난황항체
US7264810B2 (en) 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
KR100489615B1 (ko) * 2002-01-30 2005-05-17 주식회사 단바이오텍 리스테리아 모노사이토제네스 감염의 예방 및 치료를 위한항체, 이를 포함하는 알 및 이들의 제조방법
US7138252B2 (en) 2002-07-17 2006-11-21 Cytos Biotechnology Ag Molecular antigen arrays
CA2487849A1 (en) 2002-07-18 2004-01-29 Cytos Biotechnology Ag Hapten-carrier conjugates comprising virus like particles and uses thereof
EP2338510A1 (en) 2002-07-19 2011-06-29 Novartis Pharma AG Vaccine compositions containing amyloid beta1-6 antigen arrays
EP1536832A2 (en) * 2002-09-03 2005-06-08 Fondation Eurovacc Flagellin peptides as adjuvants for vaccines
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
US8420102B2 (en) 2006-03-07 2013-04-16 Vaxinnate Corporation Compositions that include hemagglutinin
US8728492B2 (en) * 2008-01-18 2014-05-20 Aeras Global Tb Vaccine Foundation Malaria vaccine compositions and constituents which elicit cell mediated immunity
AU2009236585B2 (en) 2008-04-18 2013-03-07 Vaxinnate Corporation Deletion mutants of flagellin and methods of use
WO2011028875A1 (en) * 2009-09-03 2011-03-10 Wake Forest University Health Sciences Immunogenic conjugates for producing immune responses to drugs of abuse and methods of use
CN101914144B (zh) * 2010-04-30 2013-01-09 浙江大学 金黄色葡萄球菌荚膜多糖和蛋白质偶联物及制备方法和用途
CN102580081B (zh) * 2012-02-22 2014-07-02 中国医学科学院医学生物学研究所 Nad、氢氧化铝复合佐剂及含该复合佐剂的疫苗
US8932598B2 (en) 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2674619A (en) * 1953-10-19 1954-04-06 Wyandotte Chemicals Corp Polyoxyalkylene compounds
US2979528A (en) * 1953-10-19 1961-04-11 Wyandotte Chemicals Corp Nitrogen-containing polyoxyalkylene detergent compositions
US3022335A (en) * 1955-03-30 1962-02-20 Wyandotte Chemicals Corp Surface active polyoxyalkylene compounds having a plurality of heteric polyoxypropylene-polyoxyethylene chains
US3036118A (en) * 1957-09-11 1962-05-22 Wyandotte Chemicals Corp Mixtures of novel conjugated polyoxyethylene-polyoxypropylene compounds
WO1979000160A1 (en) * 1977-09-28 1979-04-05 Nat Res Dev Improvements in or relating to immunological preparations
EP0031812B1 (en) * 1979-03-27 1983-06-15 National Research Development Corporation Improvements in or relating to immunological preparations
US4372945A (en) * 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
FR2517967A1 (fr) * 1981-12-10 1983-06-17 Air Liquide Procede de production d'un vaccin biochimique contre les fievres a salmonelles
US4711876A (en) * 1985-12-05 1987-12-08 Catapano Salvatore J Process for the treatment and remission of AIDS (acquired immune deficiency syndrome)

Also Published As

Publication number Publication date
AU629103B2 (en) 1992-09-24
EP0283505B1 (en) 1994-07-06
KR880701560A (ko) 1988-11-03
AP8700068A0 (en) 1989-03-21
NZ221868A (en) 1991-03-26
NZ236829A (en) 1993-07-27
PT85760B (pt) 1990-08-31
EP0283505A4 (en) 1989-11-07
IL83953A0 (en) 1988-02-29
CA1322721C (en) 1993-10-05
KR920002165B1 (ko) 1992-03-19
AU7113191A (en) 1991-07-11
WO1988001873A1 (en) 1988-03-24
DE3750176T2 (de) 1994-10-13
CN1030019A (zh) 1989-01-04
AU8023287A (en) 1988-04-07
IL83953A (en) 1992-05-25
EP0283505A1 (en) 1988-09-28
GR871460B (en) 1988-03-21
FI882397L (fi) 1988-05-20
FI882397A0 (fi) 1988-05-20
ATE108067T1 (de) 1994-07-15
AU613588B2 (en) 1991-08-08
DE3750176D1 (de) 1994-08-11
PT85760A (en) 1987-10-01
DK272688D0 (da) 1988-05-18
DK272688A (da) 1988-07-12
ES2007720A6 (es) 1989-07-01
JPH01501064A (ja) 1989-04-13
BR8707471A (pt) 1988-09-13

Similar Documents

Publication Publication Date Title
FI882397A7 (fi) Rokote ja valmistusmenetelmä
FI870582A7 (fi) Aminouretaaneja, niiden valmistusmenetelmä ja niiden käyttö
KR890016266A (ko) 전주 및 그 제조방법과 전주조립체
FI884830A7 (fi) Nopeasti elpyvä PTFE ja menetelmä sen valmistamiseksi
FI873180A7 (fi) Uudet hetratsepiinit ja menetelmä niiden valmistamiseksi.
FI900976A7 (fi) Päähine ja menetelmä sen valmistamiseksi
IT1205010B (it) Tetraidronaftalin-derivati e indan-derivati
FI905300A7 (fi) Menetelmä ja valmiste joissa käytetään tyyppiä II olevaa endoglykosidaasia
DE3752263D1 (de) Impfstoffe
KR880700319A (ko) 장치 및 그 제조방법
KR890010464A (ko) 풀리 및 그 제조방법
KR880701639A (ko) 화장판 및 그의 제법
KR890700300A (ko) 제어유닛 및 그 제조방법
FI884867A7 (fi) Hammastikku ja menetelmä sen valmistamiseksi
FI874025A7 (fi) Modifioidut keraamiset rakenteet ja menetelmiä näiden valmistamiseksi
KR860005810A (ko) 4h-1-벤조피란-4-온 및 그 제조방법
KR880701621A (ko) 벨트 및 그 제조방법
KR880701813A (ko) 캠축 및 캠축 제조방법
FI873905A7 (fi) Terapeuttinen koostumus ja menetelmä.
KR860005765A (ko) 강인성 세라믹스 및 그 제조방법
DE3855494D1 (de) Abfragevorrichtung und -methode
FI891331A7 (fi) Pinta-aktiivisia yhdisteitä ja niiden valmistusmenetelmä CER-2
KR870700358A (ko) 약물제조방법 및 그 용도
FI885692L (fi) Karboksimetyylisulfoetyyliselluloosa ja menetelmä sen valmistamiseksi
FI880849A7 (fi) Uudet siloksaani-bis-maleimidit ja niiden valmistusmenetelmä.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: EMORY UNIVERSITY